Atlas Trials

Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?

Clinical trial NCT01228409 · UNKNOWN

Trial details

NCT number
NCT01228409
Sponsor
Frankel, Amylynne, M.D.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Psoriasis
Start date
2010-10-01
Primary completion
2011-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.